ISCO - International Stem Cell Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue7,1657,5517,017
Cost of Revenue1,9442,0561,921
Gross Profit5,2215,4955,096
Operating Expenses
Research Development2,8562,7075,386
Selling General and Administrative7,2167,3528,390
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-4,851-4,564-8,680
Income from Continuing Operations
Total Other Income/Expenses Net3,7781,940-3,796
Earnings Before Interest and Taxes-1,073-2,624-12,476
Interest Expense6112
Income Before Tax-1,079-2,635-12,478
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-1,079-2,635-12,478
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,079-2,635-12,478
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,079-2,635-12,478